Bank of America Corp DE Grows Stake in Acadia Healthcare Company, Inc. $ACHC

Key Points

• Bank of America increased its Acadia Healthcare stake by 64.7% in the first quarter, owning 1.23 million shares valued at approximately $28.8 million, or 1.34% of the company.
• Several institutional investors also added to their positions, including Royal Bank of Canada, which increased its holdings by nearly 7,896%, and Maverick Capital, which raised its stake by 45.1%.
• Acadia exceeded quarterly earnings and revenue expectations, reporting EPS of $0.38 and revenue of $865.84 million. Analysts’ consensus rating remains Hold, with an average price target of $29.85.

Bank of America Corp DE raised its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 64.7% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,231,172 shares of the company's stock after purchasing an additional 483,649 shares during the period. Bank of America Corp DE owned about 1.34% of Acadia Healthcare worth $28,797,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Amundi lifted its stake in Acadia Healthcare by 2.9% in the first quarter. Amundi now owns 525,084 shares of the company's stock worth $12,282,000 after acquiring an additional 14,796 shares during the period. California State Teachers Retirement System increased its position in Acadia Healthcare by 34.5% during the 1st quarter. California State Teachers Retirement System now owns 113,420 shares of the company's stock valued at $2,653,000 after purchasing an additional 29,096 shares during the period. Royal Bank of Canada raised its holdings in shares of Acadia Healthcare by 7,896.1% in the 1st quarter. Royal Bank of Canada now owns 278,265 shares of the company's stock valued at $6,508,000 after purchasing an additional 274,785 shares in the last quarter. The Manufacturers Life Insurance Company raised its holdings in shares of Acadia Healthcare by 30.1% in the 1st quarter. The Manufacturers Life Insurance Company now owns 17,911 shares of the company's stock valued at $419,000 after purchasing an additional 4,140 shares in the last quarter. Finally, Maverick Capital Ltd. lifted its position in shares of Acadia Healthcare by 45.1% in the 1st quarter. Maverick Capital Ltd. now owns 1,314,116 shares of the company's stock worth $30,737,000 after purchasing an additional 408,697 shares during the period.

Analyst Ratings Changes

Several equities analysts recently issued reports on the stock. Cantor Fitzgerald reissued a "neutral" rating on shares of Acadia Healthcare in a report on Wednesday, July 29th. Raymond James Financial upgraded Acadia Healthcare from an "outperform" rating to a "strong-buy" rating and set a $39.00 target price for the company in a report on Monday, May 4th. KeyCorp increased their target price on Acadia Healthcare from $30.00 to $40.00 and gave the company an "overweight" rating in a research report on Tuesday, July 14th. Guggenheim lifted their price target on Acadia Healthcare from $38.00 to $39.00 and gave the company a "buy" rating in a report on Thursday, July 30th. Finally, UBS Group boosted their price target on Acadia Healthcare from $31.00 to $39.00 and gave the stock a "buy" rating in a research report on Thursday, July 9th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $29.85.

Acadia Healthcare Price Performance

Shares of ACHC opened at $30.83 on Monday. The company has a 50 day moving average of $29.66 and a two-hundred day moving average of $25.07. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. Acadia Healthcare Company, Inc. has a twelve month low of $11.43 and a twelve month high of $35.83. The company has a market cap of $2.87 billion, a price-to-earnings ratio of -2.48, a price-to-earnings-growth ratio of 9.98 and a beta of 0.64.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The business had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. During the same period in the prior year, the firm posted $0.83 earnings per share. The business's quarterly revenue was down .4% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, analysts predict that Acadia Healthcare Company, Inc. will post 1.54 earnings per share for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source